Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR
Market Cap: 55.5m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shedir Pharma Srl Unipersonale
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
Long-Term Investments
€16k
CAGR 3-Years
17%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Long-Term Investments
€20.8m
CAGR 3-Years
-21%
CAGR 5-Years
-7%
CAGR 10-Years
5%
P
Pierrel SpA
MIL:PRL
Long-Term Investments
€9.8k
CAGR 3-Years
-1%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Friulchem SpA
MIL:FCM
Long-Term Investments
€1.6m
CAGR 3-Years
4%
CAGR 5-Years
209%
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.59 EUR
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's Long-Term Investments?
Long-Term Investments
16k EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Long-Term Investments amounts to 16k EUR.

What is Shedir Pharma Srl Unipersonale's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
-42%

Over the last year, the Long-Term Investments growth was 60%. The average annual Long-Term Investments growth rates for Shedir Pharma Srl Unipersonale have been 17% over the past three years , -42% over the past five years .

Back to Top